ClinicalTrials.gov
public full text
Public Domain
A Clinical Study to Determine Factors Affecting Absorption and Serum Levels of Lycopene After Supplementation
Primary: To determine factors that affect absorption and serum levels of lycopene after supplementation. Secondary: 1. To evaluate general safety and tolerability of oral lycopene 15 or 30 mg per day for 12 weeks. 2. To determine lycopene effects on reducing serum levels of prostate specific antigen (PSA) and on relieving lower urinary tract symptoms (LUTS) in relation to prostate hypertrophy as evaluated by the International Prostate Symptom Score (I-PSS).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Effects of Lycopene on High Risk Prostatic Tissue#1058547
- A Pilot Study of Lycopene Supplementation in Prostatic Intraepithelial Neoplasia#1044448
- Lycopene in Preventing Prostate Cancer in Healthy Participants#825396
- Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer#877236
- Effects of LycoComfort™ Supplementation on Symptoms Associated With Lower Urinary Tract Symptoms (LUTS)#1060396
Record · ID 1162734
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive